RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,495 | +1249.4% | 152,443 | +872.2% | 0.03% | +1550.0% |
Q2 2023 | $259 | -72.9% | 15,681 | -70.8% | 0.00% | -75.0% |
Q1 2023 | $957 | -99.4% | 53,658 | +246.7% | 0.01% | +300.0% |
Q4 2021 | $154,000 | +1.3% | 15,475 | +33.4% | 0.00% | 0.0% |
Q3 2021 | $152,000 | -48.1% | 11,601 | -22.4% | 0.00% | -33.3% |
Q2 2021 | $293,000 | -2.7% | 14,944 | +10.8% | 0.00% | -62.5% |
Q2 2020 | $301,000 | -43.9% | 13,483 | -31.2% | 0.01% | -80.0% |
Q1 2019 | $537,000 | – | 19,596 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |